Anchor My Faith

Learn more

Section 7.1 Laboratory

Laboratory Report #12

Date

Collection Date: September 7, 2021
Report Date: September 8, 2021

Laboratory

Labcorp

Ordering Physician

Dr. Billy R. Boring, Jr.

Report Type

Inflammation Monitoring Evaluation

Laboratory testing included:

  • Erythrocyte Sedimentation Rate (ESR)
  • C-Reactive Protein (CRP)

Original Report

PDF: Labcorp – September 7, 2021

One-Page Summary

Purpose of Testing

This laboratory evaluation was performed as a follow-up to the inflammatory abnormalities identified on August 31, 2021. The purpose was to monitor the response of systemic inflammation by measuring two key inflammatory markers: Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP). This report provides the first evidence of a significant decline in inflammatory activity after the initial peak identified in late August 2021.

Major Findings

Inflammatory Markers

Erythrocyte Sedimentation Rate (ESR)

Result

  • Previous (August 31, 2021): 57 mm/hr
  • Current (September 7, 2021): 19 mm/hr

Reference Range:

  • 0–30 mm/hr

Interpretation

ESR decreased dramatically from a markedly elevated level of 57 mm/hr to 19 mm/hr, returning within the laboratory reference range.

This represents a substantial reduction in systemic inflammatory activity over approximately one week.

C-Reactive Protein (CRP)

Result

  • Previous (August 31, 2021): 37 mg/L
  • Current (September 7, 2021): 7 mg/L

Reference Range:

  • 0–10 mg/L

Interpretation

CRP decreased significantly from 37 mg/L to 7 mg/L, returning within the normal laboratory reference range.

Because CRP responds rapidly to changes in inflammation, this decline suggests a marked improvement in the acute inflammatory process.

Overall Interpretation

This report documents a rapid improvement in systemic inflammation following the markedly abnormal inflammatory findings identified on August 31, 2021.

Within approximately one week:

  • ESR decreased by 38 points.
  • CRP decreased by 30 mg/L.
  • Both inflammatory markers returned to normal ranges.

This improvement indicates that the inflammatory process was responsive to treatment or other changes occurring during this period. However, because the underlying cause of the inflammation was not yet fully established, continued monitoring and rheumatologic evaluation remained important.

Longitudinal Significance

This report contributes to the following trend analyses:

  • ESR Trend Table
  • CRP Trend Table
  • Systemic Inflammatory Illness Timeline
  • Rheumatology Evaluation

It represents the first documented improvement after the inflammatory peak of August 2021.

Clinical Importance

⭐⭐⭐⭐ Major Recovery Marker

Although this report contains only two laboratory values, it is highly significant because it demonstrates the first objective evidence that the severe inflammatory response was decreasing.

Key Changes Since Previous Report

Compared with August 31, 2021:

  • ESR improved from 57 mm/hr → 19 mm/hr.
  • CRP improved from 37 mg/L → 7 mg/L.
  • Both inflammatory markers returned to normal laboratory ranges.

This represents one of the fastest and most dramatic laboratory improvements documented in the Health Inventory.

Related Reports

  • August 31, 2021 – Initial Systemic Inflammatory Evaluation
  • October 2021 – Peak Inflammatory Period
  • ESR Trend Table
  • CRP Trend Table
  • Autoimmune Evaluation
  • Rheumatology Consultation Summary
  • Medical History Timeline

Navigation

  • Previous Report: August 31, 2021 – Initial Systemic Inflammatory Evaluation
  • Next Report: October 13, 2021 – Peak Systemic Inflammatory Illness Laboratory Evaluation
  • Return to Laboratory Library
  • Return to Health Inventory

Observation

This small report is actually one of the most valuable reports in the entire 2021 sequence. The August 31 report showed a clear inflammatory crisis:

  • ESR: 57
  • CRP: 37

Only one week later:

  • ESR: 19
  • CRP: 7

The Health Inventory will benefit greatly from preserving these “small” reports because they reveal the movement of disease, not just the presence of disease. A single laboratory snapshot tells where you were; a sequence of reports tells the story of what happened.